Genetic Counseling for Breast Cancer Survivors (GC for BC)
1 other identifier
interventional
157
1 country
1
Brief Summary
The purpose of this study is to review and evaluate the effectiveness of new educational materials (informational booklet \& DVD) that promote participation in genetic counseling among breast cancer survivors. There are two phases to this study: Part 1 - reviewing the newly developed educational materials, and Part 2 - evaluating the effectiveness of the newly developed educational materials
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable breast-cancer
Started Jul 2012
Longer than P75 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 27, 2012
CompletedFirst Submitted
Initial submission to the registry
May 18, 2015
CompletedFirst Posted
Study publicly available on registry
May 22, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 11, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 12, 2019
CompletedNovember 8, 2019
November 1, 2019
4 years
May 18, 2015
November 6, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Part 1: Rate of Initial Survey Responses
Intervention Development: Rate of feedback of draft materials required to complete a formative evaluation.
Up to 8 months
Part 2: Rate of Participation
Participation in the Psychoeducational Intervention (PEI) group compared to the Factsheet group.
Up to 8 months
Secondary Outcomes (1)
Rate of Impact
Up to 8 months
Study Arms (3)
Intervention Development
NO INTERVENTIONPsychoeducational Intervention (PEI) development. PEIs include printed and DVD materials, and represent a commonly used and effective approach to implement theoretically based individual-level interventions. These materials serve as important sources of information for the general public, cancer patients, and survivors from a variety of backgrounds, including populations with limited health literacy. An interview and feedback collection process will take place to provide data to improve current PEI materials.
Intervention Pilot - Intervention Group
EXPERIMENTALThe intervention group will receive the PEI materials: video and booklet. Self-reported feedback will be collected and reviewed to compare response with the control group.
Intervention Pilot - Control Group
ACTIVE COMPARATORThe control group will receive a patient factsheet about Genetic Counseling (GC). Self-reported feedback will be collected and reviewed to compare response with the intervention group.
Interventions
Printed and DVD materials about Genetic Counseling. Self-reported feedback will be collected and reviewed to compare to the control group response.
Patient factsheet about Genetic Counseling. Self-reported feedback will be collected and reviewed to compare to the intervention group response.
Eligibility Criteria
You may qualify if:
- Part 1: Female breast cancer patients at Moffitt Cancer Center (MCC) are eligible to participate if they:
- are \> 18 years of age;
- have no documented or observable psychiatric or neurological disorders that would interfere with study participation (e.g., dementia, psychosis);
- are capable of speaking and reading standard English;
- have not attended or scheduled an upcoming appointment for genetic counseling at the time of recruitment;
- are within 18 months of their breast cancer (BC) diagnosis;
- have a previous diagnosis of breast cancer or;
- received a referral letter for GC from their MCC physician;
- breast cancer at age 50 or below;
- bilateral breast cancer;
- multiple cancers except basal cell carcinoma;
- triple negative breast cancer;
- ovarian cancer or fallopian tube cancer at any age;
- of Ashkenazi Jewish descent;
- have 2 or more blood relatives diagnosed with breast cancer;
- +30 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, 33612, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susan Vadaparampil
H. Lee Moffitt Cancer Center and Research Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 18, 2015
First Posted
May 22, 2015
Study Start
July 27, 2012
Primary Completion
July 11, 2016
Study Completion
July 12, 2019
Last Updated
November 8, 2019
Record last verified: 2019-11